Trademark Overview
On Tuesday, June 25, 2024, a trademark application was filed for DEL-BRAX with the United States Patent and Trademark Office. The USPTO has given the DEL-BRAX trademark a serial number of 98617274. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, June 25, 2024. This trademark is owned by Avidity Biosciences, Inc.. The DEL-BRAX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology